Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells
- 1 May 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (9) , 1255-1260
- https://doi.org/10.1016/0006-2952(95)00045-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Ansamycins chemistry, biosynthesis and biological activityPublished by Springer Nature ,2006
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P‐glycoprotein functionFEBS Letters, 1994
- Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]Blood, 1993
- Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistanceBiochemical Pharmacology, 1992
- The role of the MDR1 (p-glycoprotein) gene in multidrug resistance in vitro and in vivoBiochemical Pharmacology, 1992
- Multidrug resistance (mdr) genes in human cancerBritish Journal of Cancer, 1991
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Multidrug ResistancePublished by Elsevier ,1989